News Room

Dr. Tinglong Dai, a professor of Operations Management and Business Analytics at the Carey School of Business, has dedicated his career to investigating the interplay between supply chains and healthcare. He says the public should not be pessimistic about the U.S. response to COVID-19 given the incredible advances with vaccine development and an unprecedented level of global data collection. 

For 14 months, Mark Domitrovich dreamed of a time when his Chicago bar and restaurants would again be filled with the buzz and chatter of happy customers. On June 11, the day he had been waiting for finally came: the state of Illinois allowed all businesses that had been affected by COVID-19 restrictions to fully reopen. 

The pandemic put a spotlight on weak links in the nation’s supply chain. There was the hunt for toilet paper at the beginning of the pandemic. Masks, surgical gowns and gloves were hard to find. These shortages were partly blamed on a “just-in-time” inventory system companies have used for decades, ordering just enough parts to come in at just the right time to sell or use on the production line. 

When members of Congress express their concern that an industry may not be making the best decisions for its long-term health, those businesses had better start guarding their wallets. 

Recently, an interim NCAA policy concerning the names, images and likeness (NIL) of student athletes has been made law in numerous states. Until now, the NCAA has banned student- athletes from earning revenue based on their athletic talent until they complete their education and officially turn professional. These NIL laws permit athletes to get a head start on translating their skills into personal revenue streams.